Behavior of cardiomyocytes and skeletal muscle cells on different extracellular matrix components - Relevance for cardiac tissue engineering

Artificial Organs

Volumn 31, Issue 1, 2007, Pages 4-12

  Macfelda, Karin ^a   Kapeller, Barbara ^a   Wilbacher, Ingrid ^a   Losert, Udo M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiomyocytes; Extracellular matrix; In vitro; Skeletal muscle cells; Tissue engineering

Indexed keywords

CELL ENGINEERING; CELLS; COATINGS; COLLAGEN; CYTOLOGY; HEART; MUSCLE; TISSUE ENGINEERING;

CARDIOMYOCYTES; CELL-BE; CELL/B.E; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX COMPONENTS; IN-VITRO; PROLIFERATION RATE; RAT SKELETAL MUSCLE; SKELETAL MUSCLE CELLS; TISSUES ENGINEERINGS;

RATS;

COLLAGEN TYPE 1; FIBRONECTIN; LAMININ;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE ENGINEERING;

EID: 33845794352     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2007.00334.x     Document Type: Article

References (21)

1. Menache P. Skeletal muscle satellite cell transplantation. Cardiovasc Res 2003;58:351-7.
2. Rosenstrauch D, Poglajen G, Zidar N, Gregoric ID. Stem cell therapy for ischemic heart failure. Tex Heart Inst J 2005;32:339-47.
3. Zammaretti P, Jaconi M. Cardiac tissue engineering: regeneration of the wounded heart. Curr Opin Biotech 2004;15:430-4.
4. Kim B-S, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998;16:224-30.
5. 1 integrins are critical for fetal ventricular myocyte proliferation. Circ Res 2000;87:508-18.
6. Lindsey ML, Mann DL, Entmann ML, Spinale FG. Extracellular matrix remodelling following myocardial injury. Ann Med 2003;35:316-26.
7. Jugdutt BI. Extracellular matrix and cardiac remodeling. In: Villareal FJ, ed. Interstitial Fibrosis in Heart Failure. New York: Springer Science+Business Media, 2005;23-57.
8. Macfelda K. Kardiales tissue engineering. Wien Klinisches Mag 2006;1:14-7.
9. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res 2005;97:1220-31.
10. Leor J, Amsalem Y, Cohen S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Therapeut 2005;105:151-63.
11. Lundgren E, Terracio L, Mardh S, Borg TK. Extracellular matrix components influence the survival of adult cardiac myocytes in vitro. Exp Cell Res 1985;158:371-81.
12. Borg TK, Rubin K, Lundrgen E, Borg K, Obrink B. Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Dev Biol 1984;104:86-96.
13. Rubin K, Borg TK, Holmdahl R, Klareskog L, Obrink B. Interactions of mammalian cells with collagen. CIBA F Symp 1984;108:93-116.
14. Lundgren E, Terracio L, Borg TK. Adhesion of cardiac myocytes to extracellular matrix components. Basic Res Cardiol 1985;80(Suppl. 1):69-74.
15. Chachques JC, Cattadori B, Herreros J, et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002;27:570-8.
16. Putnam AJ, Mooney DJ. Tissue engineering using synthetic extracellular matrices. Nat Med 1996;2:824-6.
17. Maley MA, Davies MJ, Grounds MD. Extracellular matrix, growth factors, genetics: their influence on cell proliferation and myotube formation in primary cultures of adult mouse skeletal muscle. Exp Cell Res 1995;219:169-79.
18. Lundgren E, Gullberg D, Rubin K, Borg TK, Terracio MJ, Terracio L. In vitro studies on adult cardiac myocytes: attachment and biosynthesis of collagen type IV and laminin. J Cell Physiol 1988;136:43-53.
19. Bird SD, Doevendans PA, van Pooijen MA, et al. The human adult cardiomyocyte phenotype. Cardiovasc Res 2003;58:423-34.
20. Haddad J, Decker ML, Hsieh LC, Lesch M, Samarel AM, Decker RS. Attachment and maintenance of adult rabbit cardiac myocytes in primary cell culture. Am J Physiol 1988;255:C19-C27.
21. Tyagi SC. Extracellular matrix dynamics in heart failure: a prospect for gene therapy. J Cell Biochem 1998;68:403-10.